Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05832996 · ClinicalTrials.gov registry record · Phase 4
Cool vs Room-temperature Artificial Tears
A Phase 4 study of Cystoid Macular Edema and Ocular Surface Disease, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 4
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT05832996: Completed Phase 4 study of Cystoid Macular Edema and Ocular Surface Disease, sponsored by University of Iowa.
NCT05832996 is a Phase 4 study of Cystoid Macular Edema and Ocular Surface Disease that has completed, run by University of Iowa. The registered enrollment target is 124 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05832996, a Phase 4 study of Cystoid Macular Edema and Ocular Surface Disease, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
Background and Objective: To evaluate the efficacy of cooled versus room temperature artificial tears in reducing post intravitreal injection (IVI) ocular discomfort. Patients and Methods: Patients receiving IVI were randomized to either cooled or room temperature tears intervention groups. Both groups rated their ocular discomfort following IVI before intervention and again after administration of cooled or room temperature tears.
Primary Outcome
The level of subjectively reported pain scale from 1 to 10, where 1 is minimal pain and 10 is extreme pain
Conditions Studied
Interventions
- DRUG Refresh Plus Preservative-free Lubricant Eye Drops
Study Locations (1)
Iowa
- University of Iowa Hospitals & Clinics - Department of Ophthalmology - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2022-07-06 |
| Phase | Phase 4 |
What the finished NCT05832996 record still lists
NCT05832996 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower).
The record links to 7 conditions, with Cystoid Macular Edema appearing as the primary indexed condition, and to 1 intervention - of which Refresh Plus Preservative-free Lubricant Eye Drops is the first listed.
NCT05832996 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT05832996 about?
NCT05832996 is a clinical study titled "Cool vs Room-temperature Artificial Tears". Background and Objective: To evaluate the efficacy of cooled versus room temperature artificial tears in reducing post intravitreal injection (IVI) ocular discomfort. Patients and Methods: Patients receiving IVI were randomized to either cooled or room temperature tears intervention groups. Both gr...
What is the current status of trial NCT05832996?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 124 participants. The study started on 2022-03-01. Estimated completion is 2022-07-06.
What conditions does trial NCT05832996 study?
This clinical trial studies the following conditions: Cystoid Macular Edema, Ocular Surface Disease, Central Retinal Vein Occlusion With Macular Edema, Eye Pain, Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis).
What interventions are being tested in trial NCT05832996?
The interventions under investigation include: Refresh Plus Preservative-free Lubricant Eye Drops (DRUG).
Who is sponsoring clinical trial NCT05832996?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05832996 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystoid Macular Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05832996's enrollment target sits among peer trials
124 656th of 2000 higher than 1,340 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI